Lipid imbalances hold the key to chronic inflammation in colon cancer

Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new therapeutic strategies targeting pro-inflammatory and pro-resolving lipid imbalances.

J&J expands dermatology portfolio with $850m Proteologix acquisition – Pharmaceutical Technology

J&J will gain access to Proteologix’s PX128 and PX130 for the treatment of atopic dermatitis. Credits: Skorzewiak/Shutterstock.com In a bid to solidify its footing in

May 17, 2024

Research highlights depression trends in community-dwelling older adults

Marked variation in the prevalence of depression was found in a multisite sample of community-dwelling older adults in the United States reports a study by

January 8, 2025

AstraZeneca replaces benched exec in China

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we see

December 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.